Spend on cancer per patient in England 2006 - 2007

£14,511

Compare this with other PCTs: highest amount spent was £17,028, lowest was £5,182, and average PCT spend per cancer patient was £8,437.

Exceptional funding for cancer treatment

The following information was requested from the PCT under the Freedom of Information Act.

Written protocols
The Teaching PCT has a policy on the management of interventions which are not routinely commissioned.

Cancer treatments funded by PCT following exceptional requests

Four patients were funded in financial year 2007/2008.  Treatments funded were:

• Inflixumab and dacluzimab as third line therapy for patient who could not tolerate any form of chemotherapy for a rare form of cancer
• Velcade for bone marrow cancer
• Sunitinib for renal cancer
• Velcade for myeloma

Cancer treatments not funded by PCT following exceptional requests

In the financial year 2007/2008 the following treatments were not funded:

• Nilitonib for CML
• Adjuvant Avastin for advanced colorectal cancer (two requests)
• Sunitinib for renal cancer (four requests)